FDA & Government News

Cataract Surgeons Gain a New Lens Tool

An extended depth of focus intraocular lens approved by the FDA is designed to improve visual range while maintaining contrast sensitivity in cataract surgery.

Share

The FDA has approved the TECNIS PureSee intraocular lens (IOL) for cataract surgery, a device designed to combat vision loss associated with cataracts and presbyopia. As patients age, cataracts can impair essential activities such as reading and driving. This extended depth of focus IOL aims to facilitate improved distance and intermediate vision, while offering some near vision capabilities. Notably, it is the first approved IOL in the US without warnings concerning loss of contrast sensitivity, proving effective in clinical evaluations. The lens is slated for US availability in 2026.

Original Source(s)

Cataract Surgeons Gain a New Lens Tool

  • by Kathryn Wighton

  • March 12, 2026

Related Content

Hydrus®: Designed with Purpose

Professor Norbert Pfeiffer explores the features and benefits of the Hydrus® Microstent

  • March 13, 2026

  • 4 min
Rayner Expands US Cataract Platform with Anikavisc Acquisition

Strengthens Rayner’s US cataract portfolio with a fully bundled OVD, IOL and phaco offering

  • March 13, 2026

  • 2 min
Lipid-Derived Biomarkers for NAION

TVST study reveals potential new metabolic signal in nonarteritic anterior ischemic optic neuropathy

  • March 13, 2026

  • 4 min